Skip to content
ClinCalc Pro
Menu
Antioxidant / Capillary integrity support

Ascorbic Acid (Vitamin C — High-dose Burns)

Brand names: Pabrinex IV (high-potency vitamins), Vitamin C injection

High-dose intravenous ascorbic acid (vitamin C) is used as an adjunct during early fluid resuscitation of major burns, aiming to reduce the fluid volume required and limit oxidative tissue injury.

Dosing — not shown for this use

The product information we hold does not support a dose for this page's specific use, route or population, so none is shown. Follow your local or national guideline, and confirm against the product SmPC.

Clinical monograph

How it works

As an antioxidant it scavenges reactive oxygen species generated after thermal injury, reducing microvascular permeability and capillary leak that drive burns oedema.

Prescribing in practice

  • High-dose vitamin C is contraindicated or used with great caution in patients with glucose-6-phosphate dehydrogenase deficiency because it can precipitate acute haemolysis.
  • Very high doses increase urinary oxalate and pose a risk of oxalate nephropathy and acute kidney injury, particularly with pre-existing renal impairment.
  • It can interfere with point-of-care glucometer readings, potentially causing spurious values that mislead insulin dosing.

Monitoring

Monitor renal function, urine output, acid-base status, and the reliability of bedside glucose measurements during the infusion period.

Counselling the patient

  • This is given as part of the early intensive resuscitation of a major burn.
  • The team will watch kidney function and glucose readings closely while it is running.

Evidence & guidelines

High-dose vitamin C in burns resuscitation is supported by small studies suggesting reduced fluid requirements, but evidence remains limited and its use varies between burns centres.

Reference: Tanaka H, et al. Archives of Surgery 2000; ABA Burns Resuscitation Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.